[Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000728:Androgens / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy; D002066:Busulfan / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy / Q000628:therapy*; D011830:Radiation Effects; D011859:Radiography; D013154:Spleen / Q000528:radiation effects; D013156:Splenectomy; D013163:Splenomegaly / Q000209:etiology; D013739:Testosterone / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000728:Androgens; D013739:Testosterone; D002066:Busulfan; D011241:Prednisone
Attuali possibilità terapeutiche della mielofibrosi idiopatica. Osservazioni su 47 casi.